Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Buy
71
HALO Quote, Financials, Valuation and Earnings
Last price:
$65.84
Seasonality move
:
7.09%
Day range:
$65.68 - $69.94
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
17.52x
P/S ratio:
7.82x
P/B ratio:
16.83x
Volume:
2.5M
Avg. volume:
2M
1-year change:
50.25%
Market cap:
$8.1B
Revenue:
$1B
EPS (TTM):
$3.76
Halozyme Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
HALO
Halozyme Therapeutics
|
05/07/2024 | 10-Q | 10-Q filing on 05/07/2024 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2021 | 10-Q | 10-Q filing on 11/02/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2020 | 10-Q | 10-Q filing on 11/02/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
02/24/2020 | 10-K | 10-K filing on 02/24/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
08/06/2019 | 10-Q | 10-Q filing on 08/06/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
05/07/2019 | 10-Q | 10-Q filing on 05/07/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
02/20/2018 | 10-K | 10-K filing on 02/20/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/11/2015 | 10-Q | 10-Q filing on 08/11/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
